News and Announcements
Mobotech Investor Update November 2016
- Published December 07, 2016 3:48PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
7th December 2016
Following on from last month. We met with the PepsiCo 6 Sigma team in South Carolina last week to formulate and agree the Mobot project success criteria. It was great to be included in the team to ensure deliverable expectations. These should be signed off before Xmas and over the next 6 weeks Magline will be making the necessary end effector changes to meet the agreed criteria. We expect to go to next step trials by early Feb.
Met up again with BBUSA (Bread) last week while in South Carolina. They wish to begin trials with the Mobot again, after 18 months silence. We have scheduled these for end Jan at one of their large Distribution Centres in Florida. We also had a demo of the Mobot with BMW USA. They found us searching youtube, for their need of the ‘world’s smallest forklift’. Mobot is small enough and they have scheduled a trial for late Jan.
Magline continue to support the short-term funding of the Mobots’ market awareness campaign but are awaiting sales developments before they will commit to too much more.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
